[-] Show simple item record

dc.contributor.authorSu, Cindy W.eng
dc.contributor.authorGaskie, Seaneng
dc.contributor.authorJamieson, Barbaraeng
dc.date.issued2008eng
dc.description.abstractNystatin oral suspension is a safe first-line therapy; fluconazole is more effective (strength of recommendation [SOR ]: B, 1 small randomized controlled trial [RCT]) but has not been approved by the Food and Drug Administration (FDA) for use in immunocompetent infants. Miconazole oral gel is also more effective than nystatin suspension, but is not commercially available in the United States (SOR : B, one small RCT). Gentian violet may be effective, but it stains skin and clothes and is associated with mucosal ulceration (SOR : B, 1 small retrospective cohort study).eng
dc.identifier.urihttp://hdl.handle.net/10355/3831eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2008 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 57, no. 07 (July 2008): 484-485.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectyeast infectioneng
dc.subjectantifungalseng
dc.subject.lcshThrush (Mouth disease)eng
dc.subject.lcshNystatineng
dc.subject.lcshCandidiasis -- Treatmenteng
dc.subject.lcshMiconazoleeng
dc.subject.lcshCommunicable diseases in newborn infantseng
dc.titleWhat is the best treatment for oral thrush in healthy infants?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record